Cytochrome c, somatic (CYCS); X-linked inhibitor of apoptosis (XIAP) BriefCommunication Pages: 1096 - 1096
Phosphoinositide 3-kinase (PI3K); mitogen-activated protein kinase kinase (MEK) BriefCommunication Pages: 1097 - 1097
CD160; CD244 molecule, natural killer cell receptor 2B4 (CD244; 2B4); CD274 (PD-L1); cytotoxic T lymphocyte–associated protein 4 (CTLA4); lymphocyte-activation gene 3 (CD223; LAG3); paired immunoglobin-like type 2 receptor-β (PILRβ; PIRβ); programmed cell death 1 (PDCD1; PD-1) BriefCommunication Pages: 1104 - 1104
CD274 (PD-L1); interleukin -10 receptor-α (IL-10Rα); programmed cell death 1 (PDCD1; PD-1) BriefCommunication Pages: 1105 - 1105
EGF-like repeats and discoidin I-like domains 3 (EDIL3; DEL1); lymphocyte function–associated antigen 1 (CD11a-CD18) (LFA-1) BriefCommunication Pages: 1109 - 1109
Glucose-6-phosphatase catalytic subunit (G6PC; G6Pase); nuclear receptor coactivator 2 (NCOA2; SRC2); RAR-related orphan receptor-α (RORα) BriefCommunication Pages: 1110 - 1110
Parkinson disease (autosomal recessive, juvenile) 2, parkin (PARK2) BriefCommunication Pages: 1113 - 1113
Pathways of mammalian target of rapamycin (mTOR; FRAP; RAFT1) and insulin BriefCommunication Pages: 1115 - 1115
Combined genotype-metabolite profile analysis for disease diagnosis and prognosis BriefCommunication Pages: 1116 - 1116
Identification and quantification of peptides from high-resolution mass spectrometry data BriefCommunication Pages: 1117 - 1117
In vivo, pH-sensitive fluorescent imaging of viable cancer cells BriefCommunication Pages: 1118 - 1118
Assessment of pulmonary arterial hypertension (PAH) risk in sickle cell disease patients using plasma apolipoproteins BriefCommunication Pages: 1119 - 1119
Sixteen-gene signature for prognosis of pediatric liver cancers BriefCommunication Pages: 1121 - 1121
